HF
ENVXW

HRT Financial’s Enovix Corporation Warrant ENVXW Stock Holding History

HRT Financial’s Portfolio ENVXW Stock Details ENVXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35,346
Closed -$308K – 4449
2021
Q3 		$308K Buy
+35,346
New +$249K ﹤0.01% 2391

Other funds holding ENVXW

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial's ENVXW Position: Q4 2021 in Review

HRT Financial sold out of Enovix Corporation Warrant (ENVXW) in Q4 2021, closing a stake of 35,346 shares — an estimated $308K sold.

HRT Financial first reported a position in ENVXW in Q3 2021 and held it in 1 quarter. The position peaked at $308K in Q3 2021. 15 funds tracked by Wall St. Rank hold ENVXW as of Q4 2021.

  • HRT Financial reported no remaining Enovix Corporation Warrant position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 35,346 Enovix Corporation Warrant shares in Q4 2021, an estimated $308K.
  • HRT Financial first reported a position in Enovix Corporation Warrant in Q3 2021 and held it in 1 quarter.
  • HRT Financial's Enovix Corporation Warrant position peaked at $308K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Enovix Corporation Warrant as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.